Valuation Astellas Pharma Inc.

Stocks

4503

JP3942400007

Pharmaceuticals

Market Closed - Japan Exchange 10:30:00 18/09/2026 +04			5-day change	1st Jan Change
2,383.50 ^JPY	+0.78%		+6.38%	+13.88%

09-01	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
09-01	White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies	MT

Company Valuation: Astellas Pharma Inc.

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	4,273,648	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-5.29%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	4,214,469	3,792,994	3,417,706
Change	-	-6.22%	-13.1%	23.8%	48.4%	-12.14%	-10%	-9.89%
P/E	28.5x	34.7x	173x	51x	15.5x	11.3x	11.9x	15.6x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	2.05x	1.88x	1.78x
PEG	-	-1.8x	-2.1x	0x	0x	0.4x	-2.35x	-0.7x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.83x	1.96x	2.2x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.8x	1.74x	1.76x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.69x	5.6x	5.97x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.59x	8.22x	9.13x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	9.28x	7.19x	6.96x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	10.8%	13.9%	14.4%
Dividend per Share ²	50	60	70	74	78	80.15	83.08	85.31
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.36%	3.49%	3.58%
EPS ²	67.08	54.24	9.51	28.35	162.8	210.2	199.5	153.3
Distribution rate	74.5%	111%	736%	261%	47.9%	38.1%	41.6%	55.7%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,338,001	2,179,962	1,938,212
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	740,737	677,049	572,836
EBIT ¹	155,686	133,029	25,518	41,039	382,633	490,615	461,200	374,166
Net income ¹	124,086	98,714	17,045	50,747	291,535	361,063	339,702	256,881
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-59,179	-480,654	-855,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,383.50	2,383.50	2,383.50
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,793,014	-	-
Announcement Date	27/04/22	27/04/23	25/04/24	25/04/25	27/04/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTELLAS PHARMA INC.	11.25x	1.79x	5.64x	3.39%	27.22B
ELI LILLY AND COMPANY	32.77x	11.91x	24.15x	0.6%	1,027B
JOHNSON & JOHNSON	30.06x	6.68x	18.71x	1.99%	651B
ABBVIE INC.	33.39x	7.81x	16.15x	2.6%	467B
ROCHE HOLDING AG	19.57x	4.78x	11.84x	2.77%	350B
NOVARTIS AG	19.88x	5.19x	12.87x	3.09%	268B
ASTRAZENECA PLC	21.24x	4.38x	12.5x	2.01%	257B
AMGEN INC.	24.06x	6.34x	11.29x	2.66%	205B
NOVO NORDISK A/S	12.43x	4.52x	9.45x	4.04%	190B
GILEAD SCIENCES, INC.	-45.64x	6.64x	25.94x	2.18%	187B
Average	15.90x	6.00x	14.85x	2.53%	362.93B
Weighted average by Cap.	23.56x	7.68x	17.76x	2%